Lineweaver Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
Lineweaver Wealth Advisors's BMY Position: Q2 2026 in Review
Lineweaver Wealth Advisors increased its Bristol-Myers Squibb (BMY) stake by 5.6% in Q2 2026, buying an estimated $111K and bringing the position to 36,357 shares worth $2.09M. The position accounts for 0.25% of the portfolio, ranked #86.
Lineweaver Wealth Advisors first reported a position in BMY in Q2 2021 and has held it in 13 quarters since. The position peaked at $2.34M in Q1 2023. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Lineweaver Wealth Advisors held 36,357 shares of Bristol-Myers Squibb worth $2.09M as of Q2 2026.
- Lineweaver Wealth Advisors bought 1,929 Bristol-Myers Squibb shares in Q2 2026, an estimated $111K.
- Bristol-Myers Squibb made up 0.25% of Lineweaver Wealth Advisors's portfolio in Q2 2026, its #86 holding.
- Lineweaver Wealth Advisors first reported a position in Bristol-Myers Squibb in Q2 2021 and has held it in 13 quarters since.
- Lineweaver Wealth Advisors's Bristol-Myers Squibb position peaked at $2.34M in Q1 2023.
- 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Lineweaver Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.